Laurus Labs [LAURUSLABS] vs Cipla [CIPLA] Detailed Stock Comparison
Laurus Labs
NSE
Loading...
Cipla
NSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Laurus Labs wins in 1 metrics, Cipla wins in 19 metrics, with 0 ties. Cipla appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Laurus Labs | Cipla | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 88.70 | 22.28 | Cipla |
| Price-to-Book Ratio | 10.11 | 3.85 | Cipla |
| Debt-to-Equity Ratio | 60.05 | 1.40 | Cipla |
| PEG Ratio | 35.87 | 23.40 | Cipla |
| EV/EBITDA | 38.44 | 15.51 | Cipla |
| Profit Margin (TTM) | 8.58% | 19.62% | Cipla |
| Operating Margin (TTM) | 16.90% | 22.31% | Cipla |
| EBITDA Margin (TTM) | 16.90% | 22.31% | Cipla |
| Return on Equity | 7.79% | 16.85% | Cipla |
| Return on Assets (TTM) | 3.84% | 14.10% | Cipla |
| Free Cash Flow (TTM) | $-393.50M | $34.57B | Cipla |
| Dividend Yield | 0.18% | 1.72% | Cipla |
| 1-Year Return | 92.79% | 3.58% | Laurus Labs |
| Price-to-Sales Ratio (TTM) | 7.63 | 4.37 | Cipla |
| Enterprise Value | $478.42B | $1,100.06B | Cipla |
| EV/Revenue Ratio | 8.07 | 4.00 | Cipla |
| Gross Profit Margin (TTM) | 59.39% | 68.25% | Cipla |
| Revenue per Share (TTM) | $110 | $340 | Cipla |
| Earnings per Share (Diluted) | $9.45 | $66.74 | Cipla |
| Beta (Stock Volatility) | 0.36 | 0.10 | Cipla |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Laurus Labs vs Cipla Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Laurus Labs | -1.96% | -3.24% | 5.60% | 40.07% | 31.21% | 33.49% |
| Cipla | -0.27% | -1.18% | -0.22% | -0.12% | 1.79% | 0.38% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Laurus Labs | 92.79% | 45.16% | 306.88% | 763.92% | 763.92% | 763.92% |
| Cipla | 3.58% | 45.16% | 93.18% | 101.60% | 373.56% | 979.97% |
Performance & Financial Health Analysis: Laurus Labs vs Cipla
| Metric | LAURUSLABS | CIPLA |
|---|---|---|
| Market Information | ||
| Market Cap | ₹452.51B | ₹1.20T |
| Market Cap Category | Large cap | Large cap |
| 10 Day Avg. Volume | 4,506,900 | 2,058,349 |
| 90 Day Avg. Volume | 3,124,373 | 1,602,731 |
| Last Close | ₹821.85 | ₹1,485.00 |
| 52 Week Range | ₹417.70 - ₹922.50 | ₹1,335.00 - ₹1,579.90 |
| % from 52W High | -10.91% | -6.01% |
| All-Time High | ₹922.50 (Jul 30, 2025) | ₹1,577.00 (Jul 28, 2025) |
| % from All-Time High | -10.91% | -5.83% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.31% | 0.03% |
| Quarterly Earnings Growth | 12.03% | 0.10% |
| Financial Health | ||
| Profit Margin (TTM) | 0.09% | 0.20% |
| Operating Margin (TTM) | 0.17% | 0.22% |
| Return on Equity (TTM) | 0.08% | 0.17% |
| Debt to Equity (MRQ) | 60.05 | 1.40 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹82.94 | ₹386.24 |
| Cash per Share (MRQ) | ₹2.67 | ₹131.44 |
| Operating Cash Flow (TTM) | ₹4.13B | ₹55.16B |
| Levered Free Cash Flow (TTM) | ₹3.58B | ₹52.73B |
| Dividends | ||
| Last 12-Month Dividend Yield | 0.18% | 1.72% |
| Last 12-Month Dividend | ₹1.20 | ₹26.00 |
Valuation & Enterprise Metrics Analysis: Laurus Labs vs Cipla
| Metric | LAURUSLABS | CIPLA |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 88.70 | 22.28 |
| Forward P/E | 35.87 | 23.40 |
| PEG Ratio | 35.87 | 23.40 |
| Price to Sales (TTM) | 7.63 | 4.37 |
| Price to Book (MRQ) | 10.11 | 3.85 |
| Market Capitalization | ||
| Market Capitalization | ₹452.51B | ₹1.20T |
| Enterprise Value | ₹478.42B | ₹1.10T |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 8.07 | 4.00 |
| Enterprise to EBITDA | 38.44 | 15.51 |
| Risk & Other Metrics | ||
| Beta | 0.36 | 0.10 |
| Book Value per Share (MRQ) | ₹82.94 | ₹386.24 |
Financial Statements Comparison: Laurus Labs vs Cipla
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | LAURUSLABS | CIPLA |
|---|---|---|
| Revenue/Sales | ₹15.70B | ₹68.37B |
| Cost of Goods Sold | ₹6.37B | ₹21.71B |
| Gross Profit | ₹9.32B | ₹46.66B |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | ₹2.65B | ₹15.25B |
| EBITDA | ₹3.93B | ₹20.37B |
| Pre-Tax Income | ₹2.24B | ₹17.70B |
| Income Tax | ₹631.40M | ₹4.78B |
| Net Income (Profit) | ₹1.62B | ₹12.92B |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | LAURUSLABS | CIPLA |
|---|---|---|
| Cash & Equivalents | ₹995.40M | ₹5.89B |
| Total Current Assets | ₹43.32B | ₹232.89B |
| Total Current Liabilities | ₹35.40B | ₹54.84B |
| Long-Term Debt | ₹7.08B | ₹2.52B |
| Total Shareholders Equity | ₹46.03B | ₹312.89B |
| Retained Earnings | ₹36.26B | ₹256.44B |
| Property, Plant & Equipment | ₹1.89B | ₹52.62B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | LAURUSLABS | CIPLA |
|---|---|---|
| Operating Cash Flow | N/A | N/A |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | N/A | N/A |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | LAURUSLABS | CIPLA |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 4,506,900 | 2,058,349 |
| Average Daily Volume (90 Day) | 3,124,373 | 1,602,731 |
| Shares Outstanding | 539.25M | 807.62M |
| Float Shares | 362.33M | 562.88M |
| % Held by Insiders | 0.32% | 0.31% |
| % Held by Institutions | 0.32% | 0.38% |
Dividend Analysis & Yield Comparison: Laurus Labs vs Cipla
| Metric | LAURUSLABS | CIPLA |
|---|---|---|
| Last 12-Month Dividend | ₹1.20 | ₹26.00 |
| Last 12-Month Dividend Yield | 0.18% | 1.72% |
| 3-Year Avg Annual Dividend | ₹1.33 | ₹16.00 |
| 3-Year Avg Dividend Yield | 0.16% | 0.76% |
| 3-Year Total Dividends | ₹4.00 | ₹48.00 |
| Ex-Dividend Date | May 09, 2025 | Jun 27, 2025 |